Cumberland Pharmaceuticals Inc.
CPIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $16 | $15 | $18 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $10 | $10 | $10 | $12 |
| Inventory | $3 | $3 | $4 | $4 |
| Other Curr. Assets | $1 | $2 | $2 | $3 |
| Total Curr. Assets | $30 | $31 | $32 | $36 |
| Property Plant & Equip (Net) | $8 | $7 | $7 | $6 |
| Goodwill | $1 | $1 | $1 | $1 |
| Intangibles | $15 | $16 | $17 | $18 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $12 | $12 | $13 | $14 |
| Total NC Assets | $36 | $37 | $38 | $39 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $66 | $68 | $70 | $76 |
| Liabilities | – | – | – | – |
| Payables | $14 | $13 | $14 | $14 |
| Short-Term Debt | $0 | $0 | $0 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $10 | $11 | $12 |
| Total Curr. Liab. | $24 | $24 | $26 | $32 |
| LT Debt | $10 | $10 | $10 | $15 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $6 | $6 | $6 |
| Total NC Liab. | $16 | $16 | $16 | $21 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $5 | $5 |
| Total Liabilities | $40 | $40 | $42 | $53 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $52 | $51 | $51 | $47 |
| Retained Earnings | -$25 | -$23 | -$23 | -$24 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $26 | $28 | $29 | $23 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | -$0 |
| Total Liab. & Tot. Equity | $66 | $68 | $70 | $76 |
| Net Debt | -$5 | -$6 | -$5 | $3 |